RxDoctor Payments Data

Ricky Collins, MD

Family Medicine · Whitesburg, KYNPI 1659364024

Payments from drug & device makers

$763in general payments, 2019–2025

Across 37 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$105
  • Mallinckrodt Hospital Products Inc.$88
  • AbbVie$68
  • Lilly USA, LLC$56
  • Takeda Pharmaceuticals U.S.A., Inc.$51
  • Novo Nordisk$49
  • plus $345 from 12 others

What the payments were for

  • Food & beverage$763100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$763 in reported general payments places this provider in the 50th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$11,402
Medicare patients
68
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol94$85,420
EliquisApixaban95$67,634
OzempicSemaglutide46$53,785
TrulicityDulaglutide34$36,066
XifaxanRifaximin15$31,709
XareltoRivaroxaban36$27,905
JardianceEmpagliflozin33$25,037
MounjaroTirzepatide21$21,746
JanuviaSitagliptin Phosphate16$13,368
EntrestoSacubitril/Valsartan15$12,189
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,968
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$8,277
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$7,825
SymbicortBudesonide/Formoterol Fumarate23$6,356
Albuterol Sulfate HfaAlbuterol Sulfate156$3,692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$15$91,776117 claims
Lilly USA, LLCTrulicity, Mounjaro$56$57,81255 claims
Novo NordiskOzempic$49$53,78546 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$44$31,70915 claims
AbbVieSynthroid$68$1,53922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Whitesburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →